Phase III Trial Demonstrates Molecular Profiling Safely Reduces Radiation in Endometrial Cancer and Enhances Treatment for High-Risk Patients
Endometrial cancer stands as the most prevalent gynecological malignancy in highly developed nations, predominantly affecting postmenopausal women. Historically, the prognosis ...
